Chiome Bioscience Inc.

¥74.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4583Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (17.42%)
Div yield —
ROE (60.01%)
Biotechnology
Beta (5Y) 0.15
PE TTM —
TSR TTM (42.19%)
Mkt cap ¥5.840B
ROIC (33.79%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥80
8.50%
(68.95%)
Buy 10|9|7|0|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.69
0.70
0.73
0.71
8.46%
10.71%
13.46%
10.37%
Revenue¥M
321.0
333.3
347.1
346.1
9.98%
8.48%
11.78%
6.41%
Peers (US$37.08M)
Cap (US$)
PE
38.31M
—
38.07M
—
37.98M
—
37.25M
—
Capital
TTM
5Y
10Y
Leveragex
1.250
(0.034)
(0.033)
EBIT/Intx
0.221
0.596
0.481
Own earn%
(30.92)
(159.62)
(147.16)
Sh yield%
42.20
26.82
22.19
Owners
Insiders/Inst%
0.63
41.96
Short interest%
2.39
SBC / revenue%
2.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–17
$1 testx
—
Incr. ROIC%
9